Human ARF binds E2F1 and inhibits its transcriptional activity

Béatrice Eymin(Centre National de la Recherche Scientifique), Sylvie Gazzéri(Centre National de la Recherche Scientifique)

Oncogene

March 1, 2001

10.1038/sj.onc.1204220

Cited by 160

Related Papers

Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma

|PLoS ONE|2012|148

Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin

|The EMBO Journal|2010|138

FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells

|BMC Biology|2021|121

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma

|British Journal of Cancer|2018|21

Altered splicing of <scp>ATG16‐L1</scp> mediates acquired resistance to tyrosine kinase inhibitors of <scp>EGFR</scp> by blocking autophagy in non‐small cell lung cancer

|Molecular Oncology|2022|8